| Boechler, Anna-Maria; Pelly, Dallas; Walker, Tracy; Blyth, Robert I.R.; Muir, David et al. (2025). STEM education activities at the Canadian Light Source. Canadian Journal of Chemistry 103(10) , 668-674. 10.1139/cjc-2024-0243. |
|
Peer-Reviewed Article |
|
| Fraund, Matthew; Park, Tim; Yao, Lin; Bonanno, Daniel; Pham, Don Q. et al. (2018). Quantitative capabilities of STXM to measure spatially resolved organic volume fractions of mixed organic/inorganic particle. Atmospheric Measurement Techniques Discussions , 1-27. 10.5194/amt-2018-351. |
|
Peer-Reviewed Article |
|
| Gin, Stéphane; Dillmann, Philippe; Birbilis, Nick (2017). Material degradation foreseen in the very long term: the case of glasses and ferrous metals. npj Materials Degradation 1(1) . 10.1038/s41529-017-0008-z. |
|
Peer-Reviewed Article |
|
| Wurtz, W.A. (2018). Coupling control and optimization at the Canadian Light Source. Nuclear Instruments and Methods in Physics Research. Section A: Accelerators. Spectrometers. Detectors and Associated Equipment 892, 1-9. 10.1016/j.nima.2018.02.082. |
|
Peer-Reviewed Article |
|
| (2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2. |
|
Patent |
|
| (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B. |
|
Patent |
|
| (2018). . Patent Number: NO2968312T3. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B. |
|
Patent |
|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. |
|
Patent |
|
| (2018). Methods and compositions. Patent Number: GB201817444D0. |
|
Patent |
|
| (2018). . Patent Number: NO2699601T3. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2018). Antibody epitope. Patent Number: IL256097A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|